Key Points
- Do not delay empiric antibiotics for a head CT or lumbar puncture when those procedures cannot be performed immediately.
- Ceftriaxone or cefotaxime are first-line empiric agents for community-acquired bacterial meningitis in WHO 2025 guidance.
- Add Listeria coverage when age, pregnancy, or cellular immune compromise makes it clinically relevant.
- Dexamethasone should be given before or with the first antibiotic dose when indicated.
- Head CT before LP is selective, not routine.
- CSF results can be atypical after prior antibiotics or in immunocompromised patients.
- Meningococcal disease requires infection-control precautions and contact prophylaxis planning.
- Survivors need assessment for hearing, neurologic, cognitive, and psychosocial sequelae.
Algorithm
- Recognize suspected meningitis and institute appropriate isolation when meningococcal disease is possible.
- Obtain blood cultures rapidly if this will not delay antimicrobial therapy.
- Perform lumbar puncture promptly when safe; obtain head imaging first only when clinical features justify it.
- Start empiric IV antibiotics immediately and add dexamethasone with the first dose when indicated.
- Add Listeria or resistant-pneumococcal coverage according to patient risk and local epidemiology.
- Treat shock, respiratory failure, seizure, hypoglycemia, and intracranial complications concurrently.
- Narrow therapy once microbiology and susceptibility data are available and determine organism-specific duration.
- Plan hearing, neurologic, rehabilitation, and public-health follow-up before discharge.
Clinical Synopsis & Reasoning
Adult bacterial meningitis may present with fever, headache, neck stiffness, photophobia, vomiting, altered mental status, focal neurologic deficit, or seizure, but the classic triad is absent in many patients. Older adults and immunocompromised patients can present subtly with confusion or sepsis. Meningococcal infection can produce petechiae, purpura, shock, and rapidly progressive multiorgan failure. Pneumococcus and meningococcus account for a large proportion of adult community-acquired bacterial cases, while Listeria becomes more important with older age, pregnancy, or impaired cellular immunity.
Lumbar puncture should be obtained rapidly when there is no contraindication. CSF bacterial meningitis classically shows neutrophilic pleocytosis, high protein, and low glucose, but early disease, prior antibiotics, and immunocompromise can alter the pattern. Send cell count with differential, protein, glucose with paired serum glucose, Gram stain, culture, and validated molecular testing when available. Obtain blood cultures before antibiotics if this does not delay treatment. A head CT is not a routine prerequisite for LP; reserve pre-LP imaging for patients with features suggesting mass effect or elevated herniation risk, such as focal neurologic deficit, markedly impaired consciousness, papilledema, recent seizure in selected protocols, or significant immunocompromise.
Consider viral encephalitis, subarachnoid hemorrhage, brain abscess, endocarditis with CNS emboli, leptomeningeal malignancy, autoimmune encephalitis, and toxic-metabolic encephalopathy. Herpes simplex encephalitis should remain in the differential when focal findings, temporal-lobe features, or seizures predominate, and empiric acyclovir may be needed. Infection-control precautions matter: suspected meningococcal disease requires appropriate droplet precautions and rapid public-health and contact-prophylaxis planning.
Treatment Strategy & Disposition
Administer empiric antibiotics as soon as bacterial meningitis is suspected. WHO 2025 guidance identifies ceftriaxone or cefotaxime as first-line agents. In regions with substantial penicillin- or cephalosporin-resistant pneumococcal disease, vancomycin is commonly added. Add ampicillin or amoxicillin for Listeria risk, including older adults, pregnancy, and important cellular immune compromise according to local guidance. Healthcare-associated meningitis after neurosurgery or a CSF device requires a different antipseudomonal regimen and should not be treated as ordinary community-acquired disease.
Give dexamethasone immediately before or with the first antibiotic dose when bacterial meningitis is suspected in settings where adjunctive corticosteroid therapy is recommended. Benefit is greatest when started early and is especially established for pneumococcal meningitis; delayed initiation after several antibiotic doses is less likely to help. Treat shock, hypoxemia, hypoglycemia, severe hyponatremia, and seizures while avoiding hypotonic fluid strategies that could worsen cerebral edema. Status epilepticus requires standard seizure therapy.
Admit every patient with suspected bacterial meningitis. ICU care is appropriate for shock, respiratory failure, coma, uncontrolled seizures, elevated intracranial pressure, or rapidly progressive disease. Narrow antimicrobials when organism identification and susceptibility data are available. Duration depends on the pathogen and complications. Evaluate survivors for hearing loss, vestibular dysfunction, cognitive impairment, focal deficits, seizures, and rehabilitation needs. Close contacts of meningococcal disease and selected Hib exposures require timely prophylaxis according to public-health recommendations.
Epidemiology / Risk Factors
- Bacterial meningitis remains a major cause of death and disability worldwide despite vaccination and modern antibiotics.
- Pneumococcus and meningococcus are major adult community-acquired pathogens.
- Risk is higher in older adults, immunocompromised patients, people with asplenia or complement deficiency, and those with CSF leaks or cochlear implants.
- Approximately one in five people affected by bacterial meningitis develops long-term complications according to WHO.
- Vaccination programs have substantially altered pathogen prevalence and age distribution.
Investigations
| Test | Role / Rationale | Typical Findings | Notes |
|---|---|---|---|
| Blood cultures | Identify bloodstream pathogen before antibiotics when feasible | May grow pneumococcus, meningococcus, Listeria, or other bacteria | Do not delay antibiotics for difficult culture acquisition |
| Lumbar puncture | Establishes CSF inflammatory and microbiologic pattern | Neutrophils, high protein, low glucose are classic | Send cell count, protein, glucose, Gram stain, culture, and molecular tests |
| Paired serum glucose | Interprets CSF glucose | Variable | Draw near LP timing |
| CBC/CMP | Assesses infection, organ dysfunction, sodium, renal function | Leukocytosis or leukopenia; hyponatremia possible | Guides supportive therapy and dosing |
| Head CT | Screens for mass effect in selected high-risk patients | May be normal or show edema/lesion | Not routinely required before LP |
| PCR/multiplex NAAT | Rapidly detects selected pathogens | Pathogen-specific result | Helpful after prior antibiotics but does not replace culture susceptibility data |
| Lactate/blood gas | Assesses shock and severe illness | May be elevated | Use in unstable patients |
Common Empiric Regimens (Adult)
| Population | Regimen | Additions |
|---|---|---|
| Typical community-acquired adult | Ceftriaxone or cefotaxime | Add vancomycin where resistant pneumococcus is a concern |
| Older adult, pregnancy, or cellular immune compromise | Ceftriaxone or cefotaxime plus ampicillin | Provides Listeria coverage; add vancomycin as locally indicated |
| Post-neurosurgery or CSF device | Vancomycin plus antipseudomonal beta-lactam | Healthcare-associated pathway differs from community-acquired meningitis |
Pharmacology
| Medication | Mechanism | Onset | Role in Therapy | Limitations |
|---|---|---|---|---|
| Ceftriaxone | Third-generation cephalosporin | Minutes to hours | Core empiric community-acquired meningitis therapy | Allergy, biliary effects, local resistance |
| Cefotaxime | Third-generation cephalosporin | Minutes to hours | Alternative first-line empiric therapy | Frequent dosing and allergy |
| Vancomycin | Inhibits gram-positive cell-wall synthesis | Hours | Adds resistant pneumococcal coverage where indicated | Nephrotoxicity and therapeutic monitoring |
| Ampicillin | Beta-lactam active against Listeria | Minutes to hours | Added for Listeria risk | Allergy and renal dose adjustment |
| Dexamethasone | Anti-inflammatory glucocorticoid | Hours | Reduces neurologic injury when started with initial antibiotics in selected bacterial meningitis | Benefit is timing- and pathogen-dependent |
Prognosis / Complications
- Early effective antimicrobial therapy is strongly associated with better outcome.
- Shock, coma, advanced age, pneumococcal infection, delayed treatment, and major neurologic complications worsen prognosis.
- Hearing loss, cognitive impairment, focal neurologic deficits, epilepsy, and vestibular dysfunction can persist after microbiologic cure.
- Most neurologic sequelae become clearer during recovery and may require formal rehabilitation or neuropsychologic assessment.
- Meningococcal sepsis can progress rapidly even before meningeal findings become prominent.
Patient Education / Counseling
- Explain that meningitis can cause delayed hearing or cognitive problems even after infection is cured.
- Complete the full antimicrobial course and follow infectious-disease recommendations for organism-specific care.
- Arrange hearing assessment when recommended, particularly after pneumococcal disease or any reported hearing change.
- Household and close contacts should follow public-health advice promptly if meningococcal or Hib prophylaxis is indicated.
- Review vaccination status and risk-specific vaccines before or after recovery as appropriate.
- Seek urgent reassessment for recurrent fever, worsening headache, seizure, confusion, focal weakness, or new hearing loss.
Notes
WHO released its first comprehensive global meningitis diagnosis, treatment, and care guideline in 2025. It emphasizes immediate treatment, rational use of lumbar puncture and imaging, adjunctive corticosteroids, and long-term care for sequelae.
The exact empiric regimen must still reflect local resistance patterns and the patient's age, immune status, healthcare exposures, allergy history, and renal function.
References
- WHO Guidelines on Meningitis Diagnosis Treatment and Care 2025 — Link
- IDSA Bacterial Meningitis Guideline — Link
Practice the decision pattern next.
Most students do not plateau because they refuse to study. They plateau because their review does not show the exact reasoning error behind repeated misses. MDSteps turns topic review into targeted blocks, explanations, flashcards, and readiness signals.
- Full access to 1,100+ medical reference articles linked directly to relevant QBank concepts
- 16,000+ USMLE-style questions across Step 1, Step 2 CK, and Step 3
- Depth-on-Demand™ explanations that isolate the pivot clue, distractor trap, and decision point
- CCS cases with live vitals, order timing, reassessment, and after-action feedback